Wells Fargo analyst issues OVERWEIGHT recommendation for AMZN on July 2, 2026 10:20AM ET. The previous analyst recommendation was Overweight.AMZN was trading at $241.7 at issue of the analyst recommendation.The...
Wolfe Research analyst issues OUTPERFORM recommendation for CVX on July 2, 2026 10:12AM ET. The previous analyst recommendation was Peer Perform.CVX was trading at $165.7 at issue of the analyst...
HSBC analyst issues BUY recommendation for ADBE on July 2, 2026 08:51AM ET. The previous analyst recommendation was Hold.ADBE was trading at $210.98 at issue of the analyst recommendation.The overall...
UBS analyst issues OVERWEIGHT recommendation for CRM on July 1, 2026 01:35PM ET. The previous analyst recommendation was Market Outperform.CRM was trading at $163.53 at issue of the analyst recommendation.The...
Wolfe Research analyst issues PEER PERFORM recommendation for CRM on July 1, 2026 01:35PM ET. The previous analyst recommendation was Outperform.CRM was trading at $163.53 at issue of the analyst...
Truist Financial analyst issues MARKET PERFORM recommendation for CRM on July 1, 2026 01:35PM ET. CRM was trading at $163.53 at issue of the analyst recommendation.The overall analyst consensus :...
Jefferies analyst issues BUY recommendation for CRM on July 1, 2026 01:35PM ET. The previous analyst recommendation was Buy.CRM was trading at $163.53 at issue of the analyst recommendation.The overall...
Wedbush analyst issues OUTPERFORM recommendation for CRM on July 1, 2026 01:35PM ET. The previous analyst recommendation was Outperform.CRM was trading at $163.53 at issue of the analyst recommendation.The overall...
Citigroup analyst issues BUY recommendation for CRM on July 1, 2026 01:35PM ET. The previous analyst recommendation was Market Outperform.CRM was trading at $163.53 at issue of the analyst recommendation.The...
BTIG analyst issues BUY recommendation for NKE on July 1, 2026 03:17PM ET. The previous analyst recommendation was Buy.NKE was trading at $42.875 at issue of the analyst recommendation.The overall...
